African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, Arthritis & Rheumatism, a journal of the American College of Rheumatology ...
May 10, 2012
0
0
Comorbidities are common among patients with chronic obstructive pulmonary disease (COPD), and a number of these comorbidities are independently associated with an increased mortality risk, according to a new study.
May 4, 2012
0
0
An international team of researchers led by Georgia State University scientists have found a key component in the pathological process of pulmonary fibrosis, a fatal disease for which there is currently no cure.
Apr 10, 2012
0
0
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study.
Jan 6, 2012
1
0
Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...
Jan 3, 2012
0
0
Idiopathic Pulmonary Fibrosis (IPF) is an incurable disease in which the delicate gas exchange region of the lung fills with scar tissue, which interferes with breathing. Now researchers at Duke University Medical Center ...
Dec 1, 2011
0
0
(Medical Xpress) -- Innovative technology being pioneered at Cardiff to speed up the discovery of new drugs to tackle lung diseases could also dramatically reduce testing on animals.
Nov 25, 2011
0
0
Guided by insights into how mice recover after H1N1 flu, researchers at Harvard Medical School and Brigham and Women's Hospital, together with researchers at A*STAR of Singapore, have cloned three distinct stem cells from ...
Oct 27, 2011
0
1
A panel of blood proteins can predict which patients with the progressive lung disease idiopathic pulmonary fibrosis (IPF) are likely to live at least five years or to die within two years, say researchers at the University ...
Oct 25, 2011
0
0
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic ...
Oct 21, 2011
0
0
